| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $305.4M | +50.8% |
| Cost of Revenue | $111.1M | -1.3% |
| Gross Profit | $194.4M | +116.0% |
| R&D Expense | $45.7M | -21.5% |
| SG&A Expense | $101.1M | -24.4% |
| Operating Income | -$23.2M | +87.1% |
| Pre-tax Income | -$52.6M | +70.2% |
| Income Tax | -$343K | +63.0% |
| Net Income | -$52.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.2M | -14.5% |
| Short-term Investments | $56.0M | +83.7% |
| Inventory | $10.7M | +21.3% |
| Current Assets | $198.0M | +8.6% |
| Total Assets | $419.4M | +0.1% |
| Current Liabilities | $54.8M | -6.8% |
| Long-term Debt | $55.8M | -0.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.5M | +84.2% |
| Capital Expenditures | $5.5M | +4.6% |
| Investing Cash Flow | -$30.1M | +31.1% |
| Financing Cash Flow | $44.2M | -76.3% |
| Free Cash Flow | -$34.0M | +81.7% |
| +70.3% |
| EPS (Basic) | -$1.94 | +73.2% |
| EPS (Diluted) | -$1.94 | +73.2% |
| Total Liabilities |
| $174.1M |
| -8.7% |
| Stockholders' Equity | $245.2M | +7.6% |